SLXP

Salix Pharmaceuticals, Ltd. Press Releases

$133.84
*  
0.55
0.41%
Get SLXP Alerts
*Delayed - data as of Jul. 10, 2014  -  Find a broker to begin trading SLXP now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger
7/10/2014 11:42:00 AM - PR Newswire

SALIX SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Merger between Salix and Cosmo Pharmaceuticals May be Unfair to Shareholders
7/10/2014 11:30:00 AM - Business Wire

SALIX ALERT: Proposed Sale of Salix Pharmaceuticals, Ltd. Being Investigated by Johnson & Weaver, LLP
7/9/2014 1:32:00 PM - Business Wire

Salix Pharmaceuticals to Combine with Cosmo Technologies to Form Salix Pharmaceuticals, plc
7/8/2014 5:00:00 PM - Business Wire

Salix Announces Statistically Significant Primary Endpoint Result for TARGET 3 Evaluating the Efficacy and Safety of Repeat Treatment with Rifaximin 550mg in Subjects with Irritable Bowel Syndrome with Diarrhea
7/1/2014 7:00:00 AM - Business Wire

Salix Pharmaceuticals to Host Investor Day on July 9, 2014
6/25/2014 7:00:00 AM - Business Wire

Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma
6/16/2014 7:10:00 AM - PR Newswire

Progenics Schedules Investor Conference Call Following FDA Advisory Committee
6/12/2014 3:40:00 PM - GlobeNewswire

FDA Ad Comm Provides Recommendations Regarding the Potential Cardiovascular Risk Associated with the Class of Peripherally-active Opioid Receptor Antagonists and the Trials to Support Approval of Products for OIC
6/12/2014 2:32:00 PM - Business Wire

Progenics Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Consider and Provide Recommendations Regarding Peripherally-Acting Opioid Receptor Antagonists
6/11/2014 7:05:00 AM - GlobeNewswire

Salix Pharmaceuticals to Present at Three Investment Conferences in June
5/28/2014 7:00:00 AM - Business Wire

Technical Summary on Pharma Stocks -- Research on Salix Pharma, Nektar Therapeutics, Corcept Therapeutics, and Jazz Pharma
5/12/2014 12:30:00 PM - PR Newswire

Salix Pharmaceuticals Reports 1Q2014 Results
5/8/2014 4:01:00 PM - Business Wire

Salix Pharmaceuticals to Present at Two Investment Conferences in May
5/6/2014 7:00:00 AM - Business Wire

Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2014
5/5/2014 7:00:00 AM - Business Wire

Salix Pharmaceuticals Announces 1Q2014 Financial Results Conference Call and Webcast
4/24/2014 7:00:00 AM - Business Wire

Salix Pharmaceuticals and Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand the Use of RELISTOR in Chronic Non-Cancer Pain by the European Medicines Agency
4/22/2014 7:00:00 AM - Business Wire